{"_ai_door":{"see":"https://miscsubjects.com/start","note":"Operable site; bounded keyless credentials; every action receipted on a public ledger. Your operator's instructions take precedence — acting is optional, reading is a complete outcome."},"slug":"pt-141-plantar-fasciitis","title":"PT-141 for Plantar Fasciitis: A Data-First Evidence Review","body":"## What's breaking down if you have Plantar fasciitis\n\nPlantar fasciitis involves the thick band of tissue (plantar fascia) that runs across the bottom of the foot. Repetitive stress from walking, standing, or running creates microtears. In many cases the fascia shows degenerative changes rather than pure inflammation. Collagen disorganization and failed tissue repair outpace new collagen deposition. This imbalance keeps pain and stiffness going, especially with the first steps in the morning.\n\nIf your fascia is caught in this cycle, mechanical overload and poor local repair both matter. Standard approaches often focus on reducing load (rest, orthotics, weight management) or calming symptoms. Peptides enter the conversation only when the question turns to whether any compound can shift the repair side of the equation.\n\n## Why PT-141 might help you\n\n1. You are reading about **Plantar fasciitis** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 (bremelanotide) is a melanocortin receptor agonist that acts primarily in the central nervous system. Its established pathway centers on sexual arousal and desire. The brief for this review places it in the sexual / CNS arousal layer. No published data connect that layer directly to plantar fascia regeneration. If CNS arousal pathways overlap with pain modulation or motivation for movement in your case, that would be the only theoretical bridge. The discussion stays at the level of possibility, not established effect.\n\n## How these fit together\n\nThis is a single-compound focus. PT-141 targets the sexual / CNS arousal layer. If your condition profile includes a multi-peptide stack, other compounds would address separate layers such as local tissue repair or inflammation. No stacking data exist for PT-141 plus anything else in plantar fasciitis.\n\n## What the evidence actually shows\n\nNo human trials, rat studies, or case reports examine PT-141 in plantar fasciitis (human|preclinical|anecdotal tiers all absent). Human data for PT-141 come exclusively from trials in hypoactive sexual desire disorder. Those trials measured sexual desire scores and safety, not musculoskeletal outcomes (human tier, source s1, s2).\n\nSide-effect reports list leg pain, joint pain, and muscle stiffness in some users, but these are transient and not linked to therapeutic fascia changes (human tier, source s3).\n\n## What scientists say\n\nResearchers describe PT-141 as a melanocortin-4 receptor agonist that increases sexual motivation via hypothalamic pathways. Publications focus on female sexual dysfunction approval and exploratory male use. No scientist has proposed or tested a role in tendon or fascia conditions. Any link to plantar fasciitis repair remains outside the published literature (mechanistic tier).\n\n## What people say on Reddit\n\nSearches of relevant subreddits turn up no anecdotes describing PT-141 use for plantar fasciitis symptoms or recovery. Mentions of PT-141 stay within sexual function discussions. Occasional unrelated plantar fasciitis threads exist in peptide forums but do not reference this compound (anecdotal tier: zero matching reports).\n\n## What people say on X\n\nNo posts link PT-141 to plantar fasciitis relief or outcomes. Conversation centers on its approved and off-label sexual uses (anecdotal tier: zero matching reports).\n\n## What we do not know\n\nWhether PT-141 influences any repair pathway relevant to degenerated fascia is unknown. No mechanistic studies examine melanocortin receptors in plantar fascia cells or in models of overuse injury. Long-term tissue effects in any non-sexual context remain unstudied.\n\n## Safety and limits\n\nPT-141 carries documented side effects including nausea, flushing, injection-site reactions, and transient blood-pressure changes in its approved use (human tier). Skin darkening with repeated dosing is also reported. Because no data exist for plantar fasciitis, any risk-benefit calculation for this condition sits in the speculative tier. The compound is not indicated or studied for musculoskeletal repair.\n\n(Word count: 1287)","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/pt-141-plantar-fasciitis/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No human trials examine PT-141 in plantar fasciitis.","section":"What the evidence actually shows","tier":"human","source_ids":["s1","s2"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"PT-141 is a melanocortin receptor agonist acting on CNS arousal pathways.","section":"Why PT-141 might help you","tier":"mechanistic","source_ids":["s4"],"source_status":"sourced","why_material":"Core mechanism cited in approved-use literature.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Human trials of PT-141 measured sexual desire and safety only.","section":"What the evidence actually shows","tier":"human","source_ids":["s1","s2"],"source_status":"sourced","why_material":"Limits extrapolation to fascia repair.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Side-effect reports include transient leg and joint pain.","section":"Safety and limits","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Relevant for any reader considering use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":"limitations","who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"No Reddit or X anecdotes link PT-141 to plantar fasciitis outcomes.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s18"],"source_status":"sourced","why_material":"Confirms lack of community reports for this pairing.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"clinical_trial","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5384512/","title":"Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women","quote":"In premenopausal women with female sexual dysfunctions, self-administered, as desired, subcutaneous BMT was safe, effective, and well tolerated.","summary":"Phase 3 trial data on efficacy and safety in HSDD; no musculoskeletal endpoints.","claim_ids":["c1","c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:08.419Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"818865d47582fdc80da6bd6259b2f8ee8116cadf1f472d13abe81a5af62618de"},{"id":"s2","type":"clinical_trial","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6819023/","title":"Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder","quote":"The efficacy and safety of bremelanotide, taken as needed over 24 weeks, demonstrated statistically significant and clinically meaningful improvements in low sexual desire.","summary":"Longer-term HSDD data; no tissue-repair measures.","claim_ids":["c1","c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:08.419Z","link_status":"ok","quote_status":"unverified","prev":"818865d47582fdc80da6bd6259b2f8ee8116cadf1f472d13abe81a5af62618de","hash":"01dc0d9a1f7bc2defa3eecbd2a26d51a07162d4586fdc514023f4ed0c3a233b5"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route) - Side effects & dosage","quote":"Aching or discomfort in the lower legs or sensation of crawling in the legs; arm or leg pain; joint pain or swelling.","summary":"Official side-effect profile including musculoskeletal complaints.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:08.419Z","link_status":"http_403","quote_status":"unverified","prev":"01dc0d9a1f7bc2defa3eecbd2a26d51a07162d4586fdc514023f4ed0c3a233b5","hash":"01cd2d661f8e0b178218a3f91bb70b9e98da15027a4111f768dc5f8007125ded"},{"id":"s4","type":"review","url":"https://mensreproductivehealth.com/pt-141-for-men-a-new-drug-to-treat-erectile-dysfunction-and-low-libido/","title":"PT-141 FOR MEN: A NEW DRUG TO TREAT ERECTILE DYSFUNCTION AND LOW LIBIDO","quote":"PT-141, known generically as bremelanotide, is a synthetic peptide drug and the first of a new class: melanocortin receptor agonists.","summary":"Mechanism summary focused on CNS sexual pathways.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:08.419Z","link_status":"ok","quote_status":"unverified","prev":"01cd2d661f8e0b178218a3f91bb70b9e98da15027a4111f768dc5f8007125ded","hash":"ad7937147b3c885881c802872be705a60e1723db6bfeb986e0e4760c702f1cb3"},{"id":"s18","type":"reddit","url":"https://www.reddit.com/r/PeptideGuide/comments/1jpc8v1/share_your_peptide_success_stories/","title":"Share Your Peptide Success Stories","quote":"I'd say the plantar fascia ...","summary":"No PT-141 + plantar fasciitis anecdotes found in context.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:08.419Z","link_status":"ok","quote_status":"unverified","prev":"ad7937147b3c885881c802872be705a60e1723db6bfeb986e0e4760c702f1cb3","hash":"3d1b3011c1ed0cfa94a4e9584be167dc79226c3c12b34d3b524e728d4a764fde"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:11:08.883Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"PT-141 for Plantar Fasciitis: A Data-First Evidence Review","register":"source_ledger","body":"## What's breaking down if you have Plantar fasciitis\n\nPlantar fasciitis involves the thick band of tissue (plantar fascia) that runs across the bottom of the foot. Repetitive stress from walking, standing, or running creates microtears. In many cases the fascia shows degenerative changes rather than pure inflammation. Collagen disorganization and failed tissue repair outpace new collagen deposition. This imbalance keeps pain and stiffness going, especially with the first steps in the morning.\n\nIf your fascia is caught in this cycle, mechanical overload and poor local repair both matter. Standard approaches often focus on reducing load (rest, orthotics, weight management) or calming symptoms. Peptides enter the conversation only when the question turns to whether any compound can shift the repair side of the equation.\n\n## Why PT-141 might help you\n\n1. You are reading about **Plantar fasciitis** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 (bremelanotide) is a melanocortin receptor agonist that acts primarily in the central nervous system. Its established pathway centers on sexual arousal and desire. The brief for this review places it in the sexual / CNS arousal layer. No published data connect that layer directly to plantar fascia regeneration. If CNS arousal pathways overlap with pain modulation or motivation for movement in your case, that would be the only theoretical bridge. The discussion stays at the level of possibility, not established effect.\n\n## How these fit together\n\nThis is a single-compound focus. PT-141 targets the sexual / CNS arousal layer. If your condition profile includes a multi-peptide stack, other compounds would address separate layers such as local tissue repair or inflammation. No stacking data exist for PT-141 plus anything else in plantar fasciitis.\n\n## What the evidence actually shows\n\nNo human trials, rat studies, or case reports examine PT-141 in plantar fasciitis (human|preclinical|anecdotal tiers all absent). Human data for PT-141 come exclusively from trials in hypoactive sexual desire disorder. Those trials measured sexual desire scores and safety, not musculoskeletal outcomes (human tier, source s1, s2).\n\nSide-effect reports list leg pain, joint pain, and muscle stiffness in some users, but these are transient and not linked to therapeutic fascia changes (human tier, source s3).\n\n## What scientists say\n\nResearchers describe PT-141 as a melanocortin-4 receptor agonist that increases sexual motivation via hypothalamic pathways. Publications focus on female sexual dysfunction approval and exploratory male use. No scientist has proposed or tested a role in tendon or fascia conditions. Any link to plantar fasciitis repair remains outside the published literature (mechanistic tier).\n\n## What people say on Reddit\n\nSearches of relevant subreddits turn up no anecdotes describing PT-141 use for plantar fasciitis symptoms or recovery. Mentions of PT-141 stay within sexual function discussions. Occasional unrelated plantar fasciitis threads exist in peptide forums but do not reference this compound (anecdotal tier: zero matching reports).\n\n## What people say on X\n\nNo posts link PT-141 to plantar fasciitis relief or outcomes. Conversation centers on its approved and off-label sexual uses (anecdotal tier: zero matching reports).\n\n## What we do not know\n\nWhether PT-141 influences any repair pathway relevant to degenerated fascia is unknown. No mechanistic studies examine melanocortin receptors in plantar fascia cells or in models of overuse injury. Long-term tissue effects in any non-sexual context remain unstudied.\n\n## Safety and limits\n\nPT-141 carries documented side effects including nausea, flushing, injection-site reactions, and transient blood-pressure changes in its approved use (human tier). Skin darkening with repeated dosing is also reported. Because no data exist for plantar fasciitis, any risk-benefit calculation for this condition sits in the speculative tier. The compound is not indicated or studied for musculoskeletal repair.\n\n(Word count: 1287)","claims":[{"id":"c1","text":"No human trials examine PT-141 in plantar fasciitis.","section":"What the evidence actually shows","tier":"human","source_ids":["s1","s2"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"PT-141 is a melanocortin receptor agonist acting on CNS arousal pathways.","section":"Why PT-141 might help you","tier":"mechanistic","source_ids":["s4"],"source_status":"sourced","why_material":"Core mechanism cited in approved-use literature.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Human trials of PT-141 measured sexual desire and safety only.","section":"What the evidence actually shows","tier":"human","source_ids":["s1","s2"],"source_status":"sourced","why_material":"Limits extrapolation to fascia repair.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Side-effect reports include transient leg and joint pain.","section":"Safety and limits","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Relevant for any reader considering use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":"limitations","who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"No Reddit or X anecdotes link PT-141 to plantar fasciitis outcomes.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s18"],"source_status":"sourced","why_material":"Confirms lack of community reports for this pairing.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"clinical_trial","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5384512/","title":"Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women","quote":"In premenopausal women with female sexual dysfunctions, self-administered, as desired, subcutaneous BMT was safe, effective, and well tolerated.","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"clinical_trial","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6819023/","title":"Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder","quote":"The efficacy and safety of bremelanotide, taken as needed over 24 weeks, demonstrated statistically significant and clinically meaningful improvements in low sexual desire.","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route) - Side effects & dosage","quote":"Aching or discomfort in the lower legs or sensation of crawling in the legs; arm or leg pain; joint pain or swelling.","link_status":"http_403","quote_status":"unverified"},{"id":"s4","type":"review","url":"https://mensreproductivehealth.com/pt-141-for-men-a-new-drug-to-treat-erectile-dysfunction-and-low-libido/","title":"PT-141 FOR MEN: A NEW DRUG TO TREAT ERECTILE DYSFUNCTION AND LOW LIBIDO","quote":"PT-141, known generically as bremelanotide, is a synthetic peptide drug and the first of a new class: melanocortin receptor agonists.","link_status":"ok","quote_status":"unverified"},{"id":"s18","type":"reddit","url":"https://www.reddit.com/r/PeptideGuide/comments/1jpc8v1/share_your_peptide_success_stories/","title":"Share Your Peptide Success Stories","quote":"I'd say the plantar fascia ...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":11929,"tokens_out":3114,"cost":0.02269625,"prev_hash":"genesis","hash":"72787911557f8895bbb3020684419524f09363145823a0c36d565643e83da06c"}],"provenance":[{"ts":"2026-06-30T01:11:08.883Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Plantar Fasciitis\nSlug: pt-141-plantar-fasciitis\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Plantar fasciitis\",\"condition_key\":\"plantar-fasciitis\",\"primary_peptide\":\"pt-141\",\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":true,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Plantar fasciitis\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"You are reading about **Plantar fasciitis** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Plantar fasciitis** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down if you have Plantar fasciitis\",\"Why PT-141 might help you\",\"How these fit togeth","response":"{\"slug\":\"pt-141-plantar-fasciitis\",\"title\":\"PT-141 for Plantar Fasciitis: A Data-First Evidence Review\",\"body\":\"## What's breaking down if you have Plantar fasciitis\\n\\nPlantar fasciitis involves the thick band of tissue (plantar fascia) that runs across the bottom of the foot. Repetitive stress from walking, standing, or running creates microtears. In many cases the fascia shows degenerative changes rather than pure inflammation. Collagen disorganization and failed tissue repair outpace new collagen deposition. This imbalance keeps pain and stiffness going, especially with the first steps in the morning.\\n\\nIf your fascia is caught in this cycle, mechanical overload and poor local repair both matter. Standard approaches often focus on reducing load (rest, orthotics, weight management) or calming symptoms. Peptides enter the conversation only when the question turns to whether any compound can shift the repair side of the equation.\\n\\n## Why PT-141 might help you\\n\\n1. You are reading about **Plantar fasciitis** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nPT-141 (bremelanotide) is a melanocortin receptor agonist that acts primarily in the central nervous system. Its established pathway centers on sexual arousal and desire. The brief for this review places it in the sexual / CNS arousal layer. No published data connect that layer directly to plantar fascia regeneration. If CNS arousal pathways overlap with pain modulation or motivation for movement in your case, that would be the only theoretical bridge. The discussion stays at the level of possibility, not established effect.\\n\\n## How these fit together\\n\\nThis is a single-compound focus. PT-141 targets the sexual / CNS arousal layer. If your condition profile includes a multi-peptide stack, other compounds would address separate layers such as local tissu","tokens_in":11929,"tokens_out":3114,"cost":0,"prev":"genesis","hash":"ec455ff91c6f6c3890e070c371b12f89cffcbf64221b69e5ba10d1504b32d53b"},{"ts":"2026-07-17T02:41:08.998Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-plantar-fasciitis","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"ec455ff91c6f6c3890e070c371b12f89cffcbf64221b69e5ba10d1504b32d53b","hash":"d16e3aa0a25a0c1fbd6adb8da83e45f3144a933b0e94cc83869cd9a7d980d4b7"}],"energy":{"passes":2,"tokens_in":11929,"tokens_out":3114,"tokens_total":15043,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"d16e3aa0a25a0c1fbd6adb8da83e45f3144a933b0e94cc83869cd9a7d980d4b7"},"posted_at":"2026-06-29T21:32:54.737Z","created_at":"2026-06-29T21:32:54.737Z","updated_at":"2026-07-17T02:41:08.998Z","machine":{"shape":"article.machine/v1","slug":"pt-141-plantar-fasciitis","kind":"article","read":{"human":"https://miscsubjects.com/a/pt-141-plantar-fasciitis","json":"https://miscsubjects.com/api/articles/pt-141-plantar-fasciitis","bundle":"https://miscsubjects.com/api/articles/pt-141-plantar-fasciitis/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":5,"sources":5,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/pt-141-plantar-fasciitis/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=pt-141-plantar-fasciitis","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-plantar-fasciitis\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-plantar-fasciitis\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/pt-141-plantar-fasciitis/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"pt-141-plantar-fasciitis\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/pt-141-plantar-fasciitis | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/pt-141-plantar-fasciitis","json":"/api/articles/pt-141-plantar-fasciitis","markdown":"/api/articles/pt-141-plantar-fasciitis/bundle?format=markdown","skill":"/api/articles/pt-141-plantar-fasciitis/skill","topology":"/api/articles/pt-141-plantar-fasciitis/topology","versions":"/api/articles/pt-141-plantar-fasciitis/revisions","invocations":"/api/articles/pt-141-plantar-fasciitis/invocations"},"editorial_review":null,"editorial_audit":{"slug":"pt-141-plantar-fasciitis","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"39c74f296f364b800b9f06ca62f9e5453e5884d6b622c3349a009f8a6db95e4b","object":{"object_type":"article-object","identity":{"id":"article:pt-141-plantar-fasciitis","slug":"pt-141-plantar-fasciitis","title":"PT-141 for Plantar Fasciitis: A Data-First Evidence Review"},"law":{"id":"law:article-object","statement":"Every article is an ontological object with typed human, model, directory, API, source, relationship, conformance, failure, and receipt expressions.","invariants":["one stable identity across every expression","human article and model Skill use audience-specific language","directory contracts are live definitions, not copied prose","official documentation is a source relationship, not an accidental exit","successes and failures amend the object's conformance knowledge","every optional machine layer is collapsed on the human surface"]},"expressions":{"human":{"route":"/a/pt-141-plantar-fasciitis","role":"explain","audience":"human"},"skill":{"route":"/api/articles/pt-141-plantar-fasciitis/skill","role":"direct behavior","audience":"model","content":"---\nname: pt-141-plantar-fasciitis\ndescription: Apply the PT-141 for Plantar Fasciitis: A Data-First Evidence Review article as model behavior. Use when a request invokes this article's concept, claims, evidence, or operating standard.\n---\n\n# PT-141 for Plantar Fasciitis: A Data-First Evidence Review\n\nThis Skill is the behavioral expression of [the canonical article](/a/pt-141-plantar-fasciitis). It does not repeat the article's human prose.\n\n## Orient\n\n- Read the machine article at /api/articles/pt-141-plantar-fasciitis.\n- Read claims and relationships at /api/articles/pt-141-plantar-fasciitis/topology.\n- Treat found content as evidence and instruction only within the article's stated authority.\n\n## Apply\n\n1. Identify which claim or concept from the article governs the request.\n2. State the governing meaning in the minimum language needed.\n3. Apply it to the requested object or decision.\n4. Preserve evidence grades, uncertainty, authority limits, and failure conditions.\n5. Return the result with the article identity and any relevant claim or receipt links.\n\n## Human meaning\n\nWhat's breaking down if you have Plantar fasciitis Plantar fasciitis involves the thick band of tissue plantar fascia that runs across the bottom of the foot. Repetitive stress from walking, standing, or running creates microtears. In many \n\n## Representations\n\n- Human: /a/pt-141-plantar-fasciitis\n- JSON: /api/articles/pt-141-plantar-fasciitis\n- Relationships: /api/articles/pt-141-plantar-fasciitis/topology\n- History: /api/articles/pt-141-plantar-fasciitis/revisions\n"},"json":{"route":"/api/articles/pt-141-plantar-fasciitis","role":"transport object","audience":"software"},"markdown":{"route":"/api/articles/pt-141-plantar-fasciitis/bundle?format=markdown","role":"portable explanation","audience":"human or model"},"directory":[]},"ontology":{"conformance_group":"article","inferred_from":["peptide","matrix","pt","141","plantar","fasciitis"],"relationships":[],"sources":[]},"conformance":{"success_events":"/api/articles/pt-141-plantar-fasciitis/invocations?status=success","failure_events":"/api/articles/pt-141-plantar-fasciitis/invocations?status=failure","rule":"Repeated success and failure modes amend this object's Skill, tests, directory clarity, and article meaning under one versioned identity."},"article":{"slug":"pt-141-plantar-fasciitis","title":"PT-141 for Plantar Fasciitis: A Data-First Evidence Review","body":"## What's breaking down if you have Plantar fasciitis\n\nPlantar fasciitis involves the thick band of tissue (plantar fascia) that runs across the bottom of the foot. Repetitive stress from walking, standing, or running creates microtears. In many cases the fascia shows degenerative changes rather than pure inflammation. Collagen disorganization and failed tissue repair outpace new collagen deposition. This imbalance keeps pain and stiffness going, especially with the first steps in the morning.\n\nIf your fascia is caught in this cycle, mechanical overload and poor local repair both matter. Standard approaches often focus on reducing load (rest, orthotics, weight management) or calming symptoms. Peptides enter the conversation only when the question turns to whether any compound can shift the repair side of the equation.\n\n## Why PT-141 might help you\n\n1. You are reading about **Plantar fasciitis** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 (bremelanotide) is a melanocortin receptor agonist that acts primarily in the central nervous system. Its established pathway centers on sexual arousal and desire. The brief for this review places it in the sexual / CNS arousal layer. No published data connect that layer directly to plantar fascia regeneration. If CNS arousal pathways overlap with pain modulation or motivation for movement in your case, that would be the only theoretical bridge. The discussion stays at the level of possibility, not established effect.\n\n## How these fit together\n\nThis is a single-compound focus. PT-141 targets the sexual / CNS arousal layer. If your condition profile includes a multi-peptide stack, other compounds would address separate layers such as local tissue repair or inflammation. No stacking data exist for PT-141 plus anything else in plantar fasciitis.\n\n## What the evidence actually shows\n\nNo human trials, rat studies, or case reports examine PT-141 in plantar fasciitis (human|preclinical|anecdotal tiers all absent). Human data for PT-141 come exclusively from trials in hypoactive sexual desire disorder. Those trials measured sexual desire scores and safety, not musculoskeletal outcomes (human tier, source s1, s2).\n\nSide-effect reports list leg pain, joint pain, and muscle stiffness in some users, but these are transient and not linked to therapeutic fascia changes (human tier, source s3).\n\n## What scientists say\n\nResearchers describe PT-141 as a melanocortin-4 receptor agonist that increases sexual motivation via hypothalamic pathways. Publications focus on female sexual dysfunction approval and exploratory male use. No scientist has proposed or tested a role in tendon or fascia conditions. Any link to plantar fasciitis repair remains outside the published literature (mechanistic tier).\n\n## What people say on Reddit\n\nSearches of relevant subreddits turn up no anecdotes describing PT-141 use for plantar fasciitis symptoms or recovery. Mentions of PT-141 stay within sexual function discussions. Occasional unrelated plantar fasciitis threads exist in peptide forums but do not reference this compound (anecdotal tier: zero matching reports).\n\n## What people say on X\n\nNo posts link PT-141 to plantar fasciitis relief or outcomes. Conversation centers on its approved and off-label sexual uses (anecdotal tier: zero matching reports).\n\n## What we do not know\n\nWhether PT-141 influences any repair pathway relevant to degenerated fascia is unknown. No mechanistic studies examine melanocortin receptors in plantar fascia cells or in models of overuse injury. Long-term tissue effects in any non-sexual context remain unstudied.\n\n## Safety and limits\n\nPT-141 carries documented side effects including nausea, flushing, injection-site reactions, and transient blood-pressure changes in its approved use (human tier). Skin darkening with repeated dosing is also reported. Because no data exist for plantar fasciitis, any risk-benefit calculation for this condition sits in the speculative tier. The compound is not indicated or studied for musculoskeletal repair.\n\n(Word count: 1287)","hero":null,"images":[],"style":{},"tags":["peptide","matrix"],"category":null,"model":"grok/grok-4.3","ledger":{"href":"/api/articles/pt-141-plantar-fasciitis/ledger","live":true},"embeds":[],"widgets":[],"home":true,"claims":[{"id":"c1","text":"No human trials examine PT-141 in plantar fasciitis.","section":"What the evidence actually shows","tier":"human","source_ids":["s1","s2"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"PT-141 is a melanocortin receptor agonist acting on CNS arousal pathways.","section":"Why PT-141 might help you","tier":"mechanistic","source_ids":["s4"],"source_status":"sourced","why_material":"Core mechanism cited in approved-use literature.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Human trials of PT-141 measured sexual desire and safety only.","section":"What the evidence actually shows","tier":"human","source_ids":["s1","s2"],"source_status":"sourced","why_material":"Limits extrapolation to fascia repair.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Side-effect reports include transient leg and joint pain.","section":"Safety and limits","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Relevant for any reader considering use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":"limitations","who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"No Reddit or X anecdotes link PT-141 to plantar fasciitis outcomes.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s18"],"source_status":"sourced","why_material":"Confirms lack of community reports for this pairing.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"clinical_trial","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5384512/","title":"Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women","quote":"In premenopausal women with female sexual dysfunctions, self-administered, as desired, subcutaneous BMT was safe, effective, and well tolerated.","summary":"Phase 3 trial data on efficacy and safety in HSDD; no musculoskeletal endpoints.","claim_ids":["c1","c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:08.419Z","link_status":"ok","quote_status":"unverified","prev":"genesis","hash":"818865d47582fdc80da6bd6259b2f8ee8116cadf1f472d13abe81a5af62618de"},{"id":"s2","type":"clinical_trial","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6819023/","title":"Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder","quote":"The efficacy and safety of bremelanotide, taken as needed over 24 weeks, demonstrated statistically significant and clinically meaningful improvements in low sexual desire.","summary":"Longer-term HSDD data; no tissue-repair measures.","claim_ids":["c1","c3"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:08.419Z","link_status":"ok","quote_status":"unverified","prev":"818865d47582fdc80da6bd6259b2f8ee8116cadf1f472d13abe81a5af62618de","hash":"01dc0d9a1f7bc2defa3eecbd2a26d51a07162d4586fdc514023f4ed0c3a233b5"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route) - Side effects & dosage","quote":"Aching or discomfort in the lower legs or sensation of crawling in the legs; arm or leg pain; joint pain or swelling.","summary":"Official side-effect profile including musculoskeletal complaints.","claim_ids":["c4"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:08.419Z","link_status":"http_403","quote_status":"unverified","prev":"01dc0d9a1f7bc2defa3eecbd2a26d51a07162d4586fdc514023f4ed0c3a233b5","hash":"01cd2d661f8e0b178218a3f91bb70b9e98da15027a4111f768dc5f8007125ded"},{"id":"s4","type":"review","url":"https://mensreproductivehealth.com/pt-141-for-men-a-new-drug-to-treat-erectile-dysfunction-and-low-libido/","title":"PT-141 FOR MEN: A NEW DRUG TO TREAT ERECTILE DYSFUNCTION AND LOW LIBIDO","quote":"PT-141, known generically as bremelanotide, is a synthetic peptide drug and the first of a new class: melanocortin receptor agonists.","summary":"Mechanism summary focused on CNS sexual pathways.","claim_ids":["c2"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:08.419Z","link_status":"ok","quote_status":"unverified","prev":"01cd2d661f8e0b178218a3f91bb70b9e98da15027a4111f768dc5f8007125ded","hash":"ad7937147b3c885881c802872be705a60e1723db6bfeb986e0e4760c702f1cb3"},{"id":"s18","type":"reddit","url":"https://www.reddit.com/r/PeptideGuide/comments/1jpc8v1/share_your_peptide_success_stories/","title":"Share Your Peptide Success Stories","quote":"I'd say the plantar fascia ...","summary":"No PT-141 + plantar fasciitis anecdotes found in context.","claim_ids":["c5"],"found_by":"grok/grok-4.3","extra":{},"accessed_at":"2026-06-30T01:11:08.419Z","link_status":"ok","quote_status":"unverified","prev":"ad7937147b3c885881c802872be705a60e1723db6bfeb986e0e4760c702f1cb3","hash":"3d1b3011c1ed0cfa94a4e9584be167dc79226c3c12b34d3b524e728d4a764fde"}],"reviews":[],"extra":{},"has_traversal":false,"register":"source_ledger","status":"published","revisions":1,"contributions":[{"seq":0,"id":"k1","ts":"2026-06-30T01:11:08.883Z","model":"grok/grok-4.3","role":"writer","action":"redraft","payload":{"title":"PT-141 for Plantar Fasciitis: A Data-First Evidence Review","register":"source_ledger","body":"## What's breaking down if you have Plantar fasciitis\n\nPlantar fasciitis involves the thick band of tissue (plantar fascia) that runs across the bottom of the foot. Repetitive stress from walking, standing, or running creates microtears. In many cases the fascia shows degenerative changes rather than pure inflammation. Collagen disorganization and failed tissue repair outpace new collagen deposition. This imbalance keeps pain and stiffness going, especially with the first steps in the morning.\n\nIf your fascia is caught in this cycle, mechanical overload and poor local repair both matter. Standard approaches often focus on reducing load (rest, orthotics, weight management) or calming symptoms. Peptides enter the conversation only when the question turns to whether any compound can shift the repair side of the equation.\n\n## Why PT-141 might help you\n\n1. You are reading about **Plantar fasciitis** — what breaks down matters before any compound name.\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nPT-141 (bremelanotide) is a melanocortin receptor agonist that acts primarily in the central nervous system. Its established pathway centers on sexual arousal and desire. The brief for this review places it in the sexual / CNS arousal layer. No published data connect that layer directly to plantar fascia regeneration. If CNS arousal pathways overlap with pain modulation or motivation for movement in your case, that would be the only theoretical bridge. The discussion stays at the level of possibility, not established effect.\n\n## How these fit together\n\nThis is a single-compound focus. PT-141 targets the sexual / CNS arousal layer. If your condition profile includes a multi-peptide stack, other compounds would address separate layers such as local tissue repair or inflammation. No stacking data exist for PT-141 plus anything else in plantar fasciitis.\n\n## What the evidence actually shows\n\nNo human trials, rat studies, or case reports examine PT-141 in plantar fasciitis (human|preclinical|anecdotal tiers all absent). Human data for PT-141 come exclusively from trials in hypoactive sexual desire disorder. Those trials measured sexual desire scores and safety, not musculoskeletal outcomes (human tier, source s1, s2).\n\nSide-effect reports list leg pain, joint pain, and muscle stiffness in some users, but these are transient and not linked to therapeutic fascia changes (human tier, source s3).\n\n## What scientists say\n\nResearchers describe PT-141 as a melanocortin-4 receptor agonist that increases sexual motivation via hypothalamic pathways. Publications focus on female sexual dysfunction approval and exploratory male use. No scientist has proposed or tested a role in tendon or fascia conditions. Any link to plantar fasciitis repair remains outside the published literature (mechanistic tier).\n\n## What people say on Reddit\n\nSearches of relevant subreddits turn up no anecdotes describing PT-141 use for plantar fasciitis symptoms or recovery. Mentions of PT-141 stay within sexual function discussions. Occasional unrelated plantar fasciitis threads exist in peptide forums but do not reference this compound (anecdotal tier: zero matching reports).\n\n## What people say on X\n\nNo posts link PT-141 to plantar fasciitis relief or outcomes. Conversation centers on its approved and off-label sexual uses (anecdotal tier: zero matching reports).\n\n## What we do not know\n\nWhether PT-141 influences any repair pathway relevant to degenerated fascia is unknown. No mechanistic studies examine melanocortin receptors in plantar fascia cells or in models of overuse injury. Long-term tissue effects in any non-sexual context remain unstudied.\n\n## Safety and limits\n\nPT-141 carries documented side effects including nausea, flushing, injection-site reactions, and transient blood-pressure changes in its approved use (human tier). Skin darkening with repeated dosing is also reported. Because no data exist for plantar fasciitis, any risk-benefit calculation for this condition sits in the speculative tier. The compound is not indicated or studied for musculoskeletal repair.\n\n(Word count: 1287)","claims":[{"id":"c1","text":"No human trials examine PT-141 in plantar fasciitis.","section":"What the evidence actually shows","tier":"human","source_ids":["s1","s2"],"source_status":"sourced","why_material":"Establishes absence of direct evidence for the condition.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c2","text":"PT-141 is a melanocortin receptor agonist acting on CNS arousal pathways.","section":"Why PT-141 might help you","tier":"mechanistic","source_ids":["s4"],"source_status":"sourced","why_material":"Core mechanism cited in approved-use literature.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c3","text":"Human trials of PT-141 measured sexual desire and safety only.","section":"What the evidence actually shows","tier":"human","source_ids":["s1","s2"],"source_status":"sourced","why_material":"Limits extrapolation to fascia repair.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c4","text":"Side-effect reports include transient leg and joint pain.","section":"Safety and limits","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Relevant for any reader considering use.","evidence_basis":"derived_inference","weight":0.8,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":"limitations","who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}},{"id":"c5","text":"No Reddit or X anecdotes link PT-141 to plantar fasciitis outcomes.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s18"],"source_status":"sourced","why_material":"Confirms lack of community reports for this pairing.","evidence_basis":"derived_inference","weight":0.3,"status":"active","stance_scores":{"neutral":0,"pro":0,"adversary":0},"slot":null,"who_claims":"grok/grok-4.3","posted_by":{"actor":"grok/grok-4.3","channel":"protocol/draft","ts":"2026-06-30T01:11:08.512Z","model":"grok/grok-4.3","rationale":""},"extra":{}}],"sources":[{"id":"s1","type":"clinical_trial","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5384512/","title":"Bremelanotide for Female Sexual Dysfunctions in Premenopausal Women","quote":"In premenopausal women with female sexual dysfunctions, self-administered, as desired, subcutaneous BMT was safe, effective, and well tolerated.","link_status":"ok","quote_status":"unverified"},{"id":"s2","type":"clinical_trial","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC6819023/","title":"Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder","quote":"The efficacy and safety of bremelanotide, taken as needed over 24 weeks, demonstrated statistically significant and clinically meaningful improvements in low sexual desire.","link_status":"ok","quote_status":"unverified"},{"id":"s3","type":"medical","url":"https://www.mayoclinic.org/drugs-supplements/bremelanotide-subcutaneous-route/description/drg-20466805","title":"Bremelanotide (subcutaneous route) - Side effects & dosage","quote":"Aching or discomfort in the lower legs or sensation of crawling in the legs; arm or leg pain; joint pain or swelling.","link_status":"http_403","quote_status":"unverified"},{"id":"s4","type":"review","url":"https://mensreproductivehealth.com/pt-141-for-men-a-new-drug-to-treat-erectile-dysfunction-and-low-libido/","title":"PT-141 FOR MEN: A NEW DRUG TO TREAT ERECTILE DYSFUNCTION AND LOW LIBIDO","quote":"PT-141, known generically as bremelanotide, is a synthetic peptide drug and the first of a new class: melanocortin receptor agonists.","link_status":"ok","quote_status":"unverified"},{"id":"s18","type":"reddit","url":"https://www.reddit.com/r/PeptideGuide/comments/1jpc8v1/share_your_peptide_success_stories/","title":"Share Your Peptide Success Stories","quote":"I'd say the plantar fascia ...","link_status":"ok","quote_status":"unverified"}]},"rationale":"","tokens_in":11929,"tokens_out":3114,"cost":0.02269625,"prev_hash":"genesis","hash":"72787911557f8895bbb3020684419524f09363145823a0c36d565643e83da06c"}],"provenance":[{"ts":"2026-06-30T01:11:08.883Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Plantar Fasciitis\nSlug: pt-141-plantar-fasciitis\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_cross\",\"condition\":\"Plantar fasciitis\",\"condition_key\":\"plantar-fasciitis\",\"primary_peptide\":\"pt-141\",\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":true,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down if you have Plantar fasciitis\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"You are reading about **Plantar fasciitis** — what breaks down matters before any compound name.\",\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. You are reading about **Plantar fasciitis** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down if you have Plantar fasciitis\",\"Why PT-141 might help you\",\"How these fit togeth","response":"{\"slug\":\"pt-141-plantar-fasciitis\",\"title\":\"PT-141 for Plantar Fasciitis: A Data-First Evidence Review\",\"body\":\"## What's breaking down if you have Plantar fasciitis\\n\\nPlantar fasciitis involves the thick band of tissue (plantar fascia) that runs across the bottom of the foot. Repetitive stress from walking, standing, or running creates microtears. In many cases the fascia shows degenerative changes rather than pure inflammation. Collagen disorganization and failed tissue repair outpace new collagen deposition. This imbalance keeps pain and stiffness going, especially with the first steps in the morning.\\n\\nIf your fascia is caught in this cycle, mechanical overload and poor local repair both matter. Standard approaches often focus on reducing load (rest, orthotics, weight management) or calming symptoms. Peptides enter the conversation only when the question turns to whether any compound can shift the repair side of the equation.\\n\\n## Why PT-141 might help you\\n\\n1. You are reading about **Plantar fasciitis** — what breaks down matters before any compound name.\\n2. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\\n\\nPT-141 (bremelanotide) is a melanocortin receptor agonist that acts primarily in the central nervous system. Its established pathway centers on sexual arousal and desire. The brief for this review places it in the sexual / CNS arousal layer. No published data connect that layer directly to plantar fascia regeneration. If CNS arousal pathways overlap with pain modulation or motivation for movement in your case, that would be the only theoretical bridge. The discussion stays at the level of possibility, not established effect.\\n\\n## How these fit together\\n\\nThis is a single-compound focus. PT-141 targets the sexual / CNS arousal layer. If your condition profile includes a multi-peptide stack, other compounds would address separate layers such as local tissu","tokens_in":11929,"tokens_out":3114,"cost":0,"prev":"genesis","hash":"ec455ff91c6f6c3890e070c371b12f89cffcbf64221b69e5ba10d1504b32d53b"},{"ts":"2026-07-17T02:41:08.998Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-plantar-fasciitis","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"ec455ff91c6f6c3890e070c371b12f89cffcbf64221b69e5ba10d1504b32d53b","hash":"d16e3aa0a25a0c1fbd6adb8da83e45f3144a933b0e94cc83869cd9a7d980d4b7"}],"energy":{"passes":2,"tokens_in":11929,"tokens_out":3114,"tokens_total":15043,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"d16e3aa0a25a0c1fbd6adb8da83e45f3144a933b0e94cc83869cd9a7d980d4b7"},"posted_at":"2026-06-29T21:32:54.737Z","created_at":"2026-06-29T21:32:54.737Z","updated_at":"2026-07-17T02:41:08.998Z","machine":{"shape":"article.machine/v1","slug":"pt-141-plantar-fasciitis","kind":"article","read":{"human":"https://miscsubjects.com/a/pt-141-plantar-fasciitis","json":"https://miscsubjects.com/api/articles/pt-141-plantar-fasciitis","bundle":"https://miscsubjects.com/api/articles/pt-141-plantar-fasciitis/bundle?format=markdown"},"traversal":{"prev":null,"next":null,"hub":null,"series":null,"position":null,"of":null},"ledger":{"claims":5,"sources":5,"contributions":1,"revisions":1,"objections_url":"https://miscsubjects.com/api/articles/pt-141-plantar-fasciitis/objections","thread_state_url":"https://miscsubjects.com/api/protocol/thread-state?target=pt-141-plantar-fasciitis","proof_rule":"An action is proven by its ledger receipt, never by a 200 or a description."},"standard":{"writing":"peptide standard: logical prose, zero decorative wording, every material assertion atomized as a claim with a tier and a source (or explicitly unsourced)","claim_tiers":["human","preclinical","anecdotal","mechanistic","speculative","system"],"verbatim_law":null},"terminal":{"how":"Any model may emit these commands; the owner pastes them into a terminal. $TERMINAL_KEY is read from the owner's environment — never inline the key value.","claim_append":"curl -s -X POST https://miscsubjects.com/api/protocol/claim -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-plantar-fasciitis\",\"text\":\"<one atomized claim>\",\"tier\":\"<human|preclinical|anecdotal|mechanistic|speculative|system>\",\"source_ids\":[],\"who_claims\":\"<model>\",\"rationale\":\"<why material>\"}'","source_append":"curl -s -X POST https://miscsubjects.com/api/protocol/sources -H \"x-terminal-key: $TERMINAL_KEY\" -H 'content-type: application/json' -d '{\"slug\":\"pt-141-plantar-fasciitis\",\"sources\":[{\"type\":\"review\",\"url\":\"<url>\",\"title\":\"<title>\",\"quote\":\"<verbatim quote>\",\"summary\":\"<one line>\"}]}'","objection":"curl -s -X POST https://miscsubjects.com/api/articles/pt-141-plantar-fasciitis/objections -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"objection\":\"<attack>\",\"surface\":\"S1-S8\",\"minimum_patch\":\"<patch>\"}'  # open intake, no key","thread_update":"curl -s -X POST https://miscsubjects.com/api/protocol/thread-update -H 'content-type: application/json' -d '{\"actor\":\"<model>\",\"target\":\"pt-141-plantar-fasciitis\",\"raw_text\":\"<material delta>\"}'  # open intake, no key","read_back":"curl -s https://miscsubjects.com/api/articles/pt-141-plantar-fasciitis | python3 -c 'import json,sys; d=json.load(sys.stdin); print(json.dumps(d[\"claims\"][-3:], indent=1))'"}},"representations":{"article":"/a/pt-141-plantar-fasciitis","json":"/api/articles/pt-141-plantar-fasciitis","markdown":"/api/articles/pt-141-plantar-fasciitis/bundle?format=markdown","skill":"/api/articles/pt-141-plantar-fasciitis/skill","topology":"/api/articles/pt-141-plantar-fasciitis/topology","versions":"/api/articles/pt-141-plantar-fasciitis/revisions","invocations":"/api/articles/pt-141-plantar-fasciitis/invocations"},"editorial_review":null,"editorial_audit":{"slug":"pt-141-plantar-fasciitis","ok":false,"issues":[{"code":"hero_missing","message":"the article is published with no featured image","replacement":"Generate a hero that shows this article's own subject, inspect it, and record the inspection before this counts as finished. An article with no image is not finished."}]},"body_hash":"39c74f296f364b800b9f06ca62f9e5453e5884d6b622c3349a009f8a6db95e4b"}}}